The aim of this study is to determine whether treatment of temporomandibular joint is more effective than usual care in patients with chronic migraine and temporomandibular disorders to reduce pain.
The aim of this study is to determine whether treatment of temporomandibular joint added to the control group treatment and drug therapy patient base is more effective than just using the control group treatment and drug therapy in patients with chronic migraine and temporomandibular disorders to reduce pain and improve the quality of life related to health of patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
45
6 treatments: 2 treatments for week 1 treatment = 30 minutes
once a day: 15 minutes
6 treatments: 2 treatments for week 1 treatment = 30 minutes
Universidad San Jorge
Zaragoza, Spain
Headache Impact Test (HIT-6)
Time frame: 3 months
Visual Analogue Scale (VAS)
Time frame: 3 months
Quality of life (SF-36)
Time frame: 3 months
Sleep Quality
Pittsburgh Sleep Quality Index
Time frame: 3 months
Pain threshold pressure
Pressure algometer in masticatory muscle (area trigeminal) and control point in area extra-trigeminal
Time frame: 3 months
Pain catastrophizing scale (PCS)
Time frame: 3 months
Craniofacial Pain and Disability Inventory (CF-PDI)
Time frame: 3 months
Tampa scale of Kinesiophobia (TSK)
Time frame: 3 months
Tampa scale of Kinesiophobia of cranio-mandibular disorder (TSK-TCM)
Time frame: 3 months
Maximal Mouth Opening pain free
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
once a day: 15 minutes